更新于：2024-11-21

Hydrocortisone/Fradiomycin Sulfate/Dibucaine Hydrochloride/Esculoside

氢化可的松/硫酸新霉素/盐酸地布卡因/七叶苷

更新于：2024-11-21

概要

概要

基本信息

药物类型

小分子化药

别名

ネオマイシン硫酸塩/酢酸ヒドロコルチゾン/塩酸ジフェンヒドラミン、氢化可的松/硫酸新霉素/盐酸辛可卡因/七叶苷、硫酸ネオマイシン/酢酸ヒドロコルチゾン/塩酸ジフェンヒドラミン

+ [6]

靶点-

作用机制-

治疗领域

心血管疾病消化系统疾病

在研适应症

肛裂痔疮

非在研适应症-

原研机构

EA Pharma Co., Ltd.

在研机构

EA Pharma Co., Ltd.J-DOLPH Pharmaceutical Co., Ltd.

非在研机构-

最高研发阶段批准上市

首次获批日期

日本 (1966-03-11),

肛裂痔疮

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

结构

分子式C21H30O5

InChIKeyJYGXADMDTFJGBT-VWUMJDOOSA-N

CAS号50-23-7

查看全部结构式(3)

关联

100 项与氢化可的松/硫酸新霉素/盐酸地布卡因/七叶苷相关的临床结果

登录后查看更多信息

100 项与氢化可的松/硫酸新霉素/盐酸地布卡因/七叶苷相关的转化医学

登录后查看更多信息

100 项与氢化可的松/硫酸新霉素/盐酸地布卡因/七叶苷相关的专利（医药）

登录后查看更多信息

项与氢化可的松/硫酸新霉素/盐酸地布卡因/七叶苷相关的文献（医药）

2005-07-01·The Southeast Asian journal of tropical medicine and public health4区 · 医学

Prescription pattern for treatment of hemorrhoids under the universal coverage policy of Thailand.

4区 · 医学

Article

作者: Laosee, Orapin C ; Sitthi-amorn, Chitr ; Pathanapornpandh, Nopporn ; Khiewyoo, Jiraporn ; Dulyavoranun, Namthip ; Somrongthong, Ratana

The Universal Coverage Policy (UCP) or "30 Baht Scheme" was launched in Thailand in 2001. The policy caused a cutback in the budgets of all public hospitals and health service centers. Traditional medicine was then viewed as an alternative to save costs. This study examines whether this had any influence on hemorrhoid treatment prescription patterns, ratio of traditional/modern medicine, or the cost of hemorrhoid treatment after the UCP was implemented at a community hospital. The traditional medicine prescribed was Petch Sang Kart and the modern alternative was Proctosedyl. All hemorrhoid prescriptions at a community hospital from October 2000 to January 2003 were surveyed. Segmented Regression Analysis was applied to evaluate prescription trends, the ratios between the types of medicine, and the hemorrhoid treatment cost. A total of 256 prescriptions were analyzed. The average number of traditional medicine prescriptions per month were more than modern medicine (41 versus 16). During the study period, the trend of modern medicine use and the treatment cost was decreased (p < 0.01). The ratio of traditional/modern medicine increased 0.2 times (p = 0.02).

2001-05-01·Australasian Journal of Dermatology4区 · 医学

CASE REPORT Allergic contact dermatitis to cinchocaine

4区 · 医学

Article

作者: Christopher R Kearney ; John Fewings

SUMMARYA case of allergic contact dermatitis to cinchocaine is presented to highlight the confusion regarding the classification of, and cross‐reactivity between, topical anaesthetic agents and the inadequacy of the use of benzocaine as a single screening agent for topical anaesthetic contact allergy. Our patient presented with a 10‐day history of acute perianal dermatitis. Allergic contact dermatitis to Proctosedyl® ointment, which was applied for 3 weeks prior, was suspected. On patch testing, he reacted to cinchocaine, a constituent of Proctosedyl® ointment, and to the actual product, but had no reaction to benzocaine or lignocaine.

1998-11-01·Contact Dermatitis2区 · 医学

Allergic contact dermatitis from dibucaine in Proctosedyl® ointment without cross‐sensitivity

2区 · 医学

Article

作者: Lee, A Y

100 项与氢化可的松/硫酸新霉素/盐酸地布卡因/七叶苷相关的药物交易

登录后查看更多信息